Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.59 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | KLF10 | Q13118 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.47 |
| ▸ | CNR2 | P34972 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364812 | 0.89 | KLF10 (0.62) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL122346 | 0.89 | KLF10 (0.62) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL29395400 | 0.89 | KLF10 (0.62) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL30003149 | 0.88 | KLF10 (0.61) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL13609960 | 0.88 | KLF10 (0.61) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL27179060 | 0.86 | GABRA1 (0.56) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL1980255 | 0.86 | ALDH1A1 (0.52) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL28424894 | 0.85 | GABRA1 (0.54) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL20684728 | 0.85 | GABRA1 (0.54) | GABRA1GABRB2CYP2D6ALDH1A1HPGD | |
| SCHEMBL8674767 | 0.83 | KLF10 (0.56) | GABRA1GABRB2CYP2D6ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115263-B2 | Composite materials and method for making high-performance carbon nanotube reinforced polymer composites | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2015-08-25 | — | — | US | claimed |
| US-20130264521-A1 | Composite Materials and Method for Making High-Performance Carbon Nanotube Reinforced Polymer Composites | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2013-10-10 | — | — | US | claimed |
| US-20120123061-A1 | Composite Materials and Method for Making High-Performance Carbon Nanotube Reinforced Polymer Composites | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2012-05-17 | — | — | US | claimed |
| EP-1053744-B1 | Substituted phenols as fragrance, flavor and antimicrobial compounds | TAKASAGO PERFUMERY CO LTD (JP) | 2005-04-27 | — | — | EP | claimed |
| EP-1053744-A2 | Substituted phenols as fragrance, flavor and antimicrobial compounds | Takasago International Corporation (JP) | 2000-11-22 | — | — | EP | claimed |
| US-6110888-A | PHENOL SUBSTITUTED WITH ONE OF: PROPYL OR PROPENYL; ONE OF: HYDROGEN OR ALKYL; AND ONE TO THREE C3-C5 ALKYL GROUPS; FRAGRANCE AND ANTIMICROBIAL PROPERTIES; USE SUCH AS IN MOUTHWASHES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2000-08-29 | — | — | US | claimed |
| EP-4698582-A1 | CURABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | Wacker Chemie AG (DE) | 2026-02-25 | — | — | EP | disclosed |
| US-20250145562-A1 | VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC DEVICES | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2025-05-08 | — | — | US | disclosed |
| WO-2025093198-A1 | VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC DEVICES | BAUSCH + LOMB IRELAND LIMITED (IE) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025031588-A1 | CURABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2025-02-13 | — | — | WO | disclosed |
| WO-2024217692-A1 | CURABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2024-10-24 | — | — | WO | disclosed |
| WO-2024213237-A1 | CURABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2024-10-17 | — | — | WO | disclosed |
| US-9115263-B2 | Composite materials and method for making high-performance carbon nanotube reinforced polymer composites | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2015-08-25 | — | — | US | disclosed |
| US-20080300298-A1 | Honokiol Derivates For the Treatment of Proliferative Disorders | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-12-04 | — | — | US | disclosed |
| EP-1053744-B1 | Substituted phenols as fragrance, flavor and antimicrobial compounds | TAKASAGO PERFUMERY CO LTD (JP) | 2005-04-27 | — | — | EP | disclosed |
| US-6306979-B1 | Derivatized carbon monoxide copolymers | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-23 | — | — | US | disclosed |
| US-6284868-B1 | AT LEAST ONE 1-ALKENE THAT IS AN ARYL DERIVATIVE SUBSTITUTED WITH AT LEAST ONE TERMINAL ALLYL AND/OR HOMOALLYL MOIETY AND CONTAINING ONE OR MORE POLAR GROUPS; GROUP VIII METAL COMPLEX CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-04 | — | — | US | disclosed |
| EP-1053744-A2 | Substituted phenols as fragrance, flavor and antimicrobial compounds | Takasago International Corporation (JP) | 2000-11-22 | — | — | EP | disclosed |
| US-6110888-A | PHENOL SUBSTITUTED WITH ONE OF: PROPYL OR PROPENYL; ONE OF: HYDROGEN OR ALKYL; AND ONE TO THREE C3-C5 ALKYL GROUPS; FRAGRANCE AND ANTIMICROBIAL PROPERTIES; USE SUCH AS IN MOUTHWASHES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2000-08-29 | — | — | US | disclosed |
| WO-1999058607-A1 | POLYMER MIXTURES CONTAINING CARBON MONOXIDE/α-OLEFIN COPOLYMERS AND COPOLYMERS MADE OF VINYL AROMATIC COMPOUNDS AND VINYL CYANIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145562-A1 | VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC DEVICES | CRY1, NFXL1, ZYX | GABRA1 2575/4885GABRB2 3259/4885CYP2D6 332/4885 |
| US-20080300298-A1 | Honokiol Derivates For the Treatment of Proliferative Disorders | CCNK, CDK3, CCNO | GABRA1 4042/4885GABRB2 4180/4885CYP2D6 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.